Diazepam Stada

Diazepam Stada is a prescription‑only oral medication that contains the active ingredient diazepam, a benzodiazepine classified under ATC code N05BA01. It is marketed in the European Union and supplied in tablet form, though specific strength details are not disclosed in this summary. As a positive allosteric modulator of the GABA‑A receptor, it is used to manage several central nervous system conditions for therapeutic purposes in clinical practice.

Diazepam Stada is indicated for several conditions that involve heightened central nervous system activity or muscle tension.

- Management of anxiety disorders, including generalized anxiety and panic attacks. - Short‑term relief of muscle spasms associated with musculoskeletal conditions. - Adjunctive therapy for certain seizure disorders such as status epilepticus. - Treatment of alcohol withdrawal symptoms to reduce agitation and risk of seizures. - Sedation prior to medical procedures when a rapid calming effect is required.

The pharmacological activity of diazepam may produce a range of adverse effects, which are commonly categorized by frequency. These effects can vary with dose, duration of therapy, and individual sensitivity.

Common: - Drowsiness or fatigue - Light‑headedness and dizziness - Impaired coordination or balance - Memory difficulties, especially short‑term recall - Blurred vision or visual disturbances

Serious: - Respiratory depression, particularly when combined with other depressants - Severe allergic reactions such as rash, swelling, or anaphylaxis - Paradoxical reactions including increased anxiety, agitation, or aggression - Withdrawal symptoms upon abrupt discontinuation - Depression or suicidal thoughts

Before prescribing Diazepam Stada, clinicians should evaluate several safety considerations to minimize risk.

- History of respiratory disorders such as COPD or sleep apnea. - Current or past substance use disorder, including alcohol or benzodiazepine dependence. - Concomitant use of other central nervous system depressants (e.g., opioids, antihistamines). - Pregnancy, lactation, or plans to become pregnant, due to limited safety data. - Elderly patients, who may be more susceptible to sedation and falls. - Severe hepatic impairment that may affect drug metabolism. - Known hypersensitivity to diazepam or any excipients.

Diazepam Stada can interact with a variety of medicines, altering its effectiveness or increasing adverse effects.

Avoid: - Other benzodiazepines or barbiturates, which can cause profound CNS depression. - Opioid analgesics (e.g., morphine, oxycodone) due to additive respiratory depression. - Alcohol or illicit sedatives, which markedly increase sedation and risk of overdose. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole) that raise diazepam plasma levels. - Drugs that prolong QT interval when combined with diazepam may increase cardiac risk.

Use with caution: - Antidepressants such as SSRIs or SNRIs, which may enhance serotonergic effects. - Anticonvulsants (e.g., carbamazepine, phenytoin) that can lower diazepam concentrations. - Antihistamines and muscle relaxants, which may increase drowsiness. - Herbal supplements like St. John’s wort that induce CYP enzymes.